检索

搜索所有类别
高级过滤器
关键词	删除

搜索类别
作者
标题
摘要
全文
搜扫PDF文档
补充文件
日期
从
到
索引项目
学科
类型 (method/approach)
覆盖
所有索引词字段

期

标题

作者

卷 16, 编号 2 (2019)

Drug-induced arterial hypertension

Ostroumova O., Kulikova M.

(Rus)

卷 16, 编号 4 (2019)

Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy

Oshchepkova E., Avalyan A., Rogoza A., Gorieva S., Saidova M., Chazova I.

(Rus)

卷 15, 编号 3 (2018)

Resistant and refractory arterial hypertension: similarities and differences, new approaches to diagnosis and treatment

Aksenova A., Esaulova T., Sivakova O., Chazova I.

(Rus)

卷 18, 编号 3 (2021)

Clinical features and course of arterial hypertension in patients with its various forms

Denisova A., Esaulova T., Solntseva T., Sivakova O., Chazova I.

(Rus)

卷 18, 编号 1 (2021)

Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment

Denisova A., Solntseva T., Sivakova O., Chazova I.

(Rus)

卷 10, 编号 4 (2013)

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii

Mancia G., Fagard R.

卷 14, 编号 4 (2017)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V

Chazova I., Tyulyandin S., Vitsenia M., Poltavskaya M., Gilyarov M., Martynyuk T., Ovchinnikov A., Panchenko E., Fedotkina Y., Stenina M., Trophimova O., Ageev F.

(Rus)

卷 18, 编号 1 (2021)

Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II

Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galyavich A., Rotar’ O., Khaisheva L., Kameneva T.

(Rus)

卷 17, 编号 3 (2020)

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Khaisheva L., Kameneva T.

(Rus)

卷 6, 编号 3 (2009)

Dynamics of blood pressure, heart rate variability and QTc in patients with metabolic syndrome on the selective betablockerand biguanide therapy.

Ryabykina G., Shishova T., Laptev D., Mychka V., Lyutikova L., Kozhemyakina E., Shchedrina E., Sobolev A., Chazova I.

卷 15, 编号 4 (2018)

Features of antihypertensive and vasoprotective efficiency of combination of valsartan and amlodipine in patients with obesity under different polymorphic variants of CYP2C9 and CYP11B2 genes

Kovalenko F., Skibitsky V., Fendrikova A.

(Rus)

卷 15, 编号 2 (2018)

Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion

Litvin A., Elfimova E., Chazova I.

(Rus)

卷 14, 编号 3 (2017)

The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders

Chazova I., Zhernakova Y., Blinova N., Rogoza A.

(Rus)

卷 13, 编号 4 (2016)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide

Ostroumova O., Garelik I., Karavashkina E.

(Rus)

卷 12, 编号 2 (2015)

The hardness of the vessel wall in patients with arterial hypertension

Ostroumova O., Kochetkov A., Kopchenov I., Guseva T., Bondarec O.

(Rus)

卷 11, 编号 1 (2014)

The value of blood pressure variability in clinical practice. Opportunities of amlodipine in reducing blood pressure variability (based on the Russian program «VARIATIONS»)

Ostroumova O., Bondarets O., Guseva T.

(Rus)

卷 10, 编号 4 (2013)

The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District

Chazova I., Trubacheva I., Zhernakova Y., Oshchepkova E., Serebriakova V., Kaveshnikov V., Karpov R.

卷 10, 编号 2 (2013)

Efficacy of irbesartan in arterial hypertension and metabolic syndrome

Ostroumova O., Zykova A., Polosova T., Bondarets O.

卷 10, 编号 1 (2013)

The diagnosis and treatment of patients with arterial hypertension and chronic obstructive inflammatory pulmonary diseases (Guidelines of the Russian Medical Society on Arterial Hypertension and the Russian Respiratory Society)

Chazova I., Chuchalin A., Zykov K., Ratova L.

卷 6, 编号 2 (2009)

HYVET: landmark trial voted 2008 Trialof the Year by the ImpACT/Society for Clinical Trials and the American Heart Association

卷 3, 编号 2 (2006)

Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom

Chazova I., Martynyuk T.

卷 2, 编号 1 (2005)

Kogda neobkhodimo nachinat' lechenie arterial'noy gipertonii s fiksirovannykh kombinatsiy? Novye tendentsii

Ostroumova O., Golovina O.

卷 2, 编号 1 (2005)

Sakharnyy diabet i arterial'naya gipertoniya: kakovy preparaty pervogo ryada vybora?

Shestakova M.

卷 1, 编号 1 (2004)

Rossiyskoe mnogotsentrovoe issledovanie FAGOT (farmakoekonomicheskaya otsenka ispol'zovaniya ingibitorov angiotenzinprevrashchayushchego fermenta v ambulatornom lechenii bol'nykh arterial'noy gipertoniey oslozhnennogo techeniya)

Chazova I.

卷 1, 编号 1 (2004)

Vozmozhnosti obespecheniya nefroprotektsii na fone blokady retseptorov angiotenzina II kandesartanom u bol'nykh arterial'noy gipertoniey

Chikhladze N., Chazova I.

卷 17, 编号 4 (2020)

The place of fixed antihypertensive drugs in modern therapy of arterial hypertension

Pinchuk T., Orlova N.

(Rus)

卷 16, 编号 2 (2019)

Possibilities of blood pressure and metabolic disorders correction by using diet programs in patients with overweight and obesity

Zhernakova J., Zheleznova E., Chazova I., Blinova N., Ivanov K., Starodubova A.

(Rus)

卷 16, 编号 4 (2019)

Consensus on patients with hyperuricemia and high cardiovascular risk treatment

Chazova I., Zhernakova J., Kisliak O., Nedogoda S., Podzolkov V., Oshchepkova E., Medvedeva I., Mironova O., Blinova N.

(Rus)

卷 15, 编号 4 (2018)

Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension

Agaeva R., Danilov N., Shelkova G., Sagaydak O., Grigin V., Matchin U., Chazova I.

(Rus)

卷 15, 编号 1 (2018)

The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results

Zhernakova Y., Chazova I., Oshchepkova E., Shalnova S., Konradi A., Rotar O., Yarovaya E., Shlyahto E., Boitsov S.

(Rus)

卷 15, 编号 1 (2018)

Fixed combination of amlodipine and lisinopril effectiveness in hypertensive smokers

Ostroumova O., Kochetkov A.

(Rus)

卷 14, 编号 3 (2017)

Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level

Avalyan A., Kirillova M., Shitov V., Oshchepkova Y., Saidova M., Stenina M., Chazova I.

(Rus)

卷 14, 编号 2 (2017)

A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment

Temnikova E.

(Rus)

卷 13, 编号 3 (2016)

Prolonged release verapamil: application in clinical practice

Gaponova N., Abdrakhmanov V.

(Rus)

卷 12, 编号 1 (2015)

The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome

Skibickiy V., Fendrikova A., Skibickiy A., Syrotenko D.

(Rus)

卷 11, 编号 2 (2014)

Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders

Zhernakova Y., Chazova I.

(Rus)

卷 11, 编号 1 (2014)

Hypertension treatment features in perimenopausal women

Zhernakova Y., Chazova I.

(Rus)

卷 10, 编号 3 (2013)

Vliyanie raznykh skhem antigipertenzivnoy terapii s dostizheniem tselevykh znacheniy arterial'nogo davleniya na sostoyanie funktsii pochek i vnutripochechnoe sosudistoe soprotivlenie u bol'nykh sakharnym diabetom tipa 2

Koshel'skaya O., Zhuravleva O., Karpov R.

卷 10, 编号 3 (2013)

Blokatory kal'tsievykh kanalov III pokoleniya pri lechenii arterial'noy gipertonii

Shilov A.

卷 3, 编号 2 (2006)

Primenenie ingibitorov angiotenzinprevrashchayushchego fermenta v lechenii arterial'noy gipertonii

Galyavich A.

卷 2, 编号 2 (2005)

Vozmozhnosti korrektsii endotelial'noy disfunktsii ingibitorami angiotenzinprevrashchayushchego fermenta

Gorokhovskaya G., Petina M., Akatova E., Aksenov I., Martynov A.

卷 1, 编号 2 (2004)

Samokontrol' arterial'nogo davleniya patsientami povyshaet priverzhennost' k lecheniyu arterial'noy gipertonii (nablyudenie 1 god)

Oshchepkova E., Tsagareishvili E., Rogoza A.

卷 1, 编号 2 (2004)

Pervye rezul'taty Rossiyskoy programmy po izucheniyu effektivnosti primeneniya akarbozy u patsientov s narushennoy tolerantnost'yu k glyukoze i arterial'noy gipertoniey (APREL')

Chazova I., Mychka V., Belenkov Y.

卷 18, 编号 3 (2021)

Management of patients with arterial hypertension and atrial fibrillation

Chazova I., Golitsyn S., Zhernakova J., Zheleznova E., Kropacheva E., Mironov N., Kostiukevich M., Laiovich L., Utsumueva M., Iuricheva I., Litvin A., Elfimova E., Rogoza A., Panchenko E.

(Rus)

卷 17, 编号 4 (2020)

Primary hyperaldosteronism as a possible cause of resistant arterial hypertension

Chikhladze N.

(Rus)

卷 17, 编号 1 (2020)

Radiofrequency renal denervation with mono-electrode and multi-electrode device for treatment in patient with uncontrolled hypertension: results of a 6-month follow-up

Agaeva R., Danilov N., Shchcelkova G., Matchin Y., Chazova I.

(Rus)

卷 16, 编号 3 (2019)

Features of arterial hypertension patients with discrepancies in vectorcardiographic and echocardiographic conclusions about the presence of left ventricular hypertrophy [Original Article]

Blinova E., Sakhnova T., Chaykovskaya O., Saidova M., Ryabykina G.

(Rus)

卷 6, 编号 4 (2009)

Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)

Chazova I., Ostroumova O.

卷 15, 编号 1 (2018)

The place of intervention methods of treatment of patients with resistant hypertension in clinical practice

Agaeva R., Danilov N., Sagaydak O., Chazova I.

(Rus)

卷 14, 编号 1 (2017)

Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients

Zhernakova Y., Martyniuk T., Arkhipova O., Azimova M., Rogoza A., Chazova I.

(Rus)

卷 13, 编号 4 (2016)

Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension

Shchelkova G., Zairova A., Danilov N., Rogoza A., Chazova I.

(Rus)

卷 12, 编号 1 (2015)

The role of beta-blockers in the treatment of arterial hypertension: what do we know today

Zhernakova Y., Chazova I.

(Rus)

卷 12, 编号 2 (2015)

Heart rate in patients with arterial hypertension:a possible marker of high risk or independent therapeutic target?

Kobalava Z., Shavarova E.

(Rus)

卷 11, 编号 4 (2014)

Local rigidity of the walls of the carotid artery at the site of formation of atherosclerotic plaques in patients with arterial hypertension

Vakhovskaya T., Tripoten M., Pogorelova O., Balakhonova T., Loukianov M., Boytsov S.

(Rus)

卷 11, 编号 4 (2014)

Methods of sympathetic activity evaluation in patients with systemic refractory hypertension

Grigin V., Danilov N., Sagaydak O., Shelkova G., Chazova I.

(Rus)

卷 11, 编号 2 (2014)

The benefits of candesartan usage in the treatment of arterial hypertension

Ostroumova O., Bondarets O., Guseva T.

(Rus)

卷 11, 编号 1 (2014)

Experience of treating hypertension in an outpatient setting: a clinical case

Agafonov A., Khozyainova N., Petruschenkova O.

(Rus)

卷 11, 编号 1 (2014)

Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components

Zhernakova Y., Sharipova G., Chazova I.

(Rus)

卷 10, 编号 4 (2013)

Coagulogic risk factors of heart disease in the adult population of Tomsk

Dobrovolsky A., Titaeva E., Yarovaya E., Storozhilova A., Zhernakova Y., Oschepkova E., Panchenko E., Trubacheva I., Serebryakova V., Kaveshnikova V., Chazova I., Karpov R.

卷 10, 编号 2 (2013)

A modern phylogenetic theory of pathology, pathogenesis of essential arterial hypertension and universal algorhythm of damage to the target organs

Titov V.

卷 2, 编号 1 (2005)

Antagonisty kal'tsiya v lechenii arterial'noy gipertonii (issledovanie ETNA)

Chazova I., Ratova L.

卷 1, 编号 1 (2004)

Gipotenzivnaya effektivnost' novoy lekarstvennoy formy metoprolola zamedlennogo vysvobozhdeniya u bol'nykh s arterial'noy gipertoniey

Belousov Y., Leonova M., Erofeeva S.

卷 1, 编号 1 (2004)

Arterial'naya gipertoniya i ishemicheskaya bolezn' serdtsa: poisk optimal'nykh podkhodov k lecheniyu (po rezul'tatam issledovaniya INVEST)

Chazova I.

卷 18, 编号 1 (2021)

Etiopathogenesis, diagnosis, and approaches to the treatment of arterial hypertension: an assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project

Bontsevich R., Vovk Y., Gavrilova A., Kirichenko A., Ebzeeva E., Kosmacheva E., Kompaniets O., Prozorova G., Nevzorova V., Martynenko I., Barysheva V., Ketova G., Maksimov M., Osipova O.

(Rus)

卷 18, 编号 4 (2021)

Knowledge of senior students in the definition, classification, and approaches to the treatment of arterial hypertension. Final results of the PHYSTARH project

Bontsevich R., Vovk Y., Gavrilova A., Batishcheva G., Goncharova N., Elizarova I., Ketova G., Barysheva V., Bikkinina G., Myronenko O.

(Rus)

卷 17, 编号 1 (2020)

Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2

Chazova I., Shestakova M., Zhernakova Y., Markova T., Mazurina N., Yezhov M., Mironova O., Litvin A., Elfimova E., Blinova N., Sukhareva O., Ametov A., Akhmedzhanov N., Kislyak O., Kukharchuk V., Nedogoda S., Nebieridze D., Medvedev I., Mkrtumyan A., Podzolkov V.

(Rus)

卷 16, 编号 3 (2019)

The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus

Zhernakova J., Chazova I., Blinova N.

(Rus)

卷 16, 编号 3 (2019)

Target levels of blood pressure in the elderly and very old patients with chronic kidney disease without frailty

Ostroumova O., Cherniaeva M.

(Rus)

卷 15, 编号 4 (2018)

The relationship between the antihypertensive effect of b-adrenergic blockers and the initial daily variability of sinus rhythm

Sobolev A., Talabanov P., Ryabykina G., Kozhemyakina E.

(Rus)

卷 14, 编号 4 (2017)

Modern concepts of the relationship between obesity and erectile dysfunction in patients with arterial hypertension

Alekseeva T., Litvin A.

(Rus)

卷 14, 编号 2 (2017)

Advantages azilsartan medoxomil in patients with arterial hypertension: how to make a choice and to optimize antihypertensive therapy?

Martynyuk T., Chazova I.

(Rus)

卷 14, 编号 1 (2017)

The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension

Elfimova E., Rvacheva A., Tripoten M., Pogorelova O., Balakhonova T., Zykov K., Litvin A.

(Rus)

卷 13, 编号 3 (2016)

Application of advanced electrovectorcardiographic methods in the diagnosis of left ventricular hypertrophy on the basis of Uryupinsk central district hospital

Vishnyakova N., Ryabykina G., Sakhnova T., Blinova E., Kozhemiakina E., Volkov V.

(Rus)

卷 12, 编号 3 (2015)

Radiofrequency denervation of renal arteries. Myth or reality?

Grigin V., Danilov N., Matchin Y., Chazova I.

(Rus)

卷 12, 编号 1 (2015)

Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach

Zhernakova Y., Sharipova G., Chazova I.

(Rus)

卷 11, 编号 3 (2014)

The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects

Gilyarevsky S.

(Rus)

卷 11, 编号 3 (2014)

Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol

Baryshnikov G., Stepanova I., Kudryavtseva N.

(Rus)

卷 11, 编号 2 (2014)

The functional state of microcirculatory vessels in patients with arterial hypertension I-II degree with different degrees of cardiovascular risk

Mordvinova E., Oschepkova E., Fedorovich A., Rogoza A.

(Rus)

卷 10, 编号 3 (2013)

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii

Mancia G., Fagard R.

卷 10, 编号 1 (2013)

Effect of the fixed-dose combination Ekvator on blood pressure level and cognitive functions in elderly patients with arterial hypertension

Ostroumova O., Pervichko E.

卷 3, 编号 2 (2006)

Pri vsem bogatstve vybora drugoy al'ternativy net Issledovanie ETNA Plyus (ETNA v zhizni vracha polikliniki)

Chazova I., Ratova L.

卷 2, 编号 2 (2005)

Arterial'naya gipertoniya i tserebrovaskulyarnye narusheniya

Skvortsova V.

卷 1, 编号 2 (2004)

Kognitivnye funktsii u patsientov s arterial'noy gipertenziey: vliyanie gipotenzivnoy terapii

Ostroumova O., Desnitskaya I.

卷 18, 编号 2 (2021)

Comparative characteristics of indicators of peripheral arterial and central aortic pressure, remodeling of the left ventricular myocardium in salt-sensitive and salt-resistant patients with arterial hypertension

Skibitskiy V., Vasil'ev V., Fendrikova A., Pyatakov S.

(Rus)

卷 17, 编号 3 (2020)

Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease

Chazova I., Nevzorova V., Ambatiello L., Brodskaia T., Oshchepkova E., Belevskii A., Zhernakova J., Aisanov Z., Ovcharenko S., Chuchalin A.

(Rus)

卷 17, 编号 3 (2020)

Speckle-tracking echocardiography in 3D mode in assessing the deformation of the myocardium and identifying subclinical cardiotoxicity during chemotherapy in breast cancer patients with arterial hypertension

Avalyan A., Saidova M., Oshchepkova E., Chazova I.

(Rus)

卷 16, 编号 4 (2019)

New approaches to the analysis of daily variability of sinus rhythm in assessing the antihypertensive effect of various drugs

Sobolev A., Talabanov P., Ryabykina G., Kozhemyakina E., Oshchepkova E.

(Rus)

卷 16, 编号 2 (2019)

Orthostatic reactions and cognitive dysfunctions in elderly and senile patients with arterial hypertension

Atyunina I., Oschepkova E., Rogoza A., Lazareva N.

(Rus)

卷 6, 编号 4 (2009)

Rationale for the use of sartans in patients with arterial hypertension

Stryuk R.

卷 15, 编号 4 (2018)

Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity

Zheleznova E., Zhernakova Y., Chazova I., Rogoza A., Zairova A., Shariya M., Yarovaya E., Orlovsky A., Blinova N., Azimova M., Gorieva S., Konosova I.

(Rus)

卷 15, 编号 4 (2018)

The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities

Ostroumova O., Kochetkov A.

(Rus)

卷 15, 编号 3 (2018)

Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]

Chazova I., Zhernakova Y.

(Rus)

卷 14, 编号 2 (2017)

Clinical efficacy of sympathetic denervation of renal arteries in patients with resistant arterial hypertension as part of annual prospective follow-up

Gapon L., Mikova E., Savelyeva N., Kolunin G., Zherzhova A.

(Rus)

卷 13, 编号 2 (2016)

Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs

Ostroumova O., Zykova A., Maksimov M.

(Rus)

卷 13, 编号 2 (2016)

The major arteries and skin microcirculatory vessels status and antihypertensive therapy effect on them in hypertensive patients with high and very high cardiovascular risk

Mordvinova E., Oshchepkova E., Fedorovich A., Zairova A., Pogorelova O., Tripoten M., Rogoza A.

(Rus)

卷 13, 编号 1 (2016)

The role of b-blockers in treatment of hypertension, according to Russian and European experts

Ostroumova O., Fomina V., Shchukina G., Smoliarchuk E.

(Rus)

卷 12, 编号 3 (2015)

The prevalence of renal dysfunction in arterial hypertension (in the framework of the ESSE-RF study)

Oshchepkova E., Dolgusheva I., Zhernakova I., Chazova I., Shal'nova S., Iarovaia E., Rotar' O., Konradi A., Boitsov S.

(Rus)

卷 11, 编号 4 (2014)

The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches

Gilyarevsky S., Kuzmina I., Golshmid M.

(Rus)

卷 11, 编号 4 (2014)

The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders

Zhernakov Y., Chazova I.

(Rus)

卷 11, 编号 3 (2014)

The impact of fixed combination of amlodipine and perindopril (drug Prestance)on the mechanisms of heat adaptation in patients with arterial hypertension

Ageev F., Smirnova M., Fofanova T., Svirida O., Mikhailov G., Revich B.

(Rus)

1 - 100 的 174 信息 1 2 > >>

检索提示:

检索的名词区分大小写
常用字词将被忽略
默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
使用引号检索一个完整的词组; 例如： "open access publishing"
使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 83918 от 12.09.2022 г.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 83917 от 12.09.2022 г.

用户名
密码
记住我

忘记您的密码?	注册

用户名
密码
记住我

忘记您的密码?	注册

检索

高级过滤器

搜索类别

日期

索引项目

检索提示: